Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates

Vaccine

Volumn 30, Issue 38, 2012, Pages 5603-5610

  Boonnak, Kobporn ^a   Paskel, Myeisha ^a   Matsuoka, Yumiko ^a   Vogel, Leatrice ^a   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Influenza vaccine; Non human primate; Pandemic H1N1

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNITY; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LUNG; MALE; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RHESUS MONKEY; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT; VIRUS REPLICATION; VIRUS TITRATION;

ADAPTATION, BIOLOGICAL; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BLOOD; CERCOPITHECUS AETHIOPS; COLD TEMPERATURE; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; IMMUNOGLOBULIN A; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; MACACA MULATTA; MALE; NASAL MUCOSA; ORTHOMYXOVIRIDAE INFECTIONS; PRIMATE DISEASES; REASSORTANT VIRUSES; RESPIRATORY SYSTEM; VACCINES, ATTENUATED; VIRAL LOAD; VIRUS REPLICATION;

EID: 84864748968     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.088     Document Type: Article

References (33)

1. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
2. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324:1557-1561.
3. Girard M.P., Tam J.S., Assossou O.M., Kieny M.P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28:4895-4902.
4. Min J.Y., Chen G.L., Santos C., Lamirande E.W., Matsuoka Y., Subbarao K. Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology 2010, 408:128-133.
5. Chen G.L., Min J.Y., Lamirande E.W., Santos C., Jin H., Kemble G., et al. Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J Infect Dis 2011, 203:930-936.
6. Suguitan A.L., Cheng X., Wang W., Wang S., Jin H., Lu S. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. PLoS One 2011, 6:e21942.
7. Karron R.A., Talaat K., Luke C., Callahan K., Thumar B., Dilorenzo S., et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 2009, 27:4953-4960.
8. Grizzard M.B., London W.T., Sly D.L., Murphy B.R., James W.D., Parnell W.P., et al. Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus. Infect Immun 1978, 21:201-205.
9. Murphy B.R., Sly D.L., Hosier N.T., London W.T., Chanock R.M. Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys. Infect Immun 1980, 28:688-691.
10. Baskin C.R., Garcia-Sastre A., Tumpey T.M., Bielefeldt-Ohmann H., Carter V.S., Nistal-Villan E., et al. Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J Virol 2004, 78:10420-10432.
11. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
12. Herfst S., van den Brand J.M., Schrauwen E.J., de Wit E., Munster V.J., van Amerongen G., et al. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet Pathol 2010, 47:1040-1047.
13. Safronetz D., Rockx B., Feldmann F., Belisle S.E., Palermo R.E., Brining D., et al. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 2011, 85:1214-1223.
14. Rimmelzwaan G.F., Kuiken T., van Amerongen G., Bestebroer T.M., Fouchier R.A., Osterhaus A.D. A primate model to study the pathogenesis of influenza A (H5N1) virus infection. Avian Dis 2003, 47:931-933.
15. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009, 106:3455-3460.
16. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445:319-323.
17. Chen Z., Wang W., Zhou H., Suguitan A.L., Shambaugh C., Kim L., et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 2010, 84:44-51.
18. Stephenson I., Wood J.M., Nicholson K.G., Zambon M.C. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol 2003, 70:391-398.
19. Chen G.L., Lamirande E.W., Jin H., Kemble G., Subbarao K. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 2010, 398:109-114.
20. Chen G.L., Lau Y.F., Lamirande E.W., McCall A.W., Subbarao K. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci USA 2010, 108:1140-1145.
21. Joseph T., McAuliffe J., Lu B., Jin H., Kemble G., Subbarao K. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol 2007, 81:10558-10566.
22. Lau Y.F., Santos C., Torres-Velez F.J., Subbarao K. The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines. J Virol 2010, 85:76-85.
23. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 2003, 306:18-24.
24. Kuiken T., Rimmelzwaan G.F., Van Amerongen G., Osterhaus A.D. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet Pathol 2003, 40:304-310.
25. Chen Y., Deng W., Jia C., Dai X., Zhu H., Kong Q., et al. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch Virol 2009, 154:227-233.
26. Rimmelzwaan G.F., Baars M., van Beek R., van Amerongen G., Lovgren-Bengtsson K., Claas E.C., et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 1997, 78(Pt. 4):757-765.
27. O'Donnell C.D., Subbarao K. The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect 2011, 13:502-515.
28. Gill J.R., Sheng Z.M., Ely S.F., Guinee D.G., Beasley M.B., Suh J., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010, 134:235-243.
29. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
30. Gu J., Xie Z., Gao Z., Liu J., Korteweg C., Ye J., et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007, 370:1137-1145.
31. Carmona F., Carlotti A.P., Ramalho L.N., Costa R.S., Ramalho F.S. Evidence of renal infection in fatal cases of 2009 pandemic Influenza A (H1N1). Am J Clin Pathol 2011, 136:416-423.
32. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4:e1000115.
33. Yang P., Duan Y., Wang C., Xing L., Gao X., Tang C., et al. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Vaccine 2011, 29:698-705.